Hicon Solution
NDC Package 65174-880-00
Package Information
Hicon (sodium iodide i 131) solution is hICON® is indicated for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. This formulation utilizes a solution delivery system. Marketed by Jubilant Draximage Inc., Dba Jubilant Radiopharma, this product is identified by NDC 65174-880 and is authorized under FDA application NDA021305.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65174 - Jubilant Draximage Inc., Dba Jubilant Radiopharma
- 65174-880 - Hicon
- 65174-880-00 - 1 VIAL in 1 KIT / 1 mL in 1 VIAL
- 65174-880 - Hicon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65174-880). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65174-880-00 identifies a specific commercial package of 1 vial in 1 kit / 1 ml in 1 vial of Hicon, a human prescription drug labeled by Jubilant Draximage Inc., Dba Jubilant Radiopharma. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This solution is formulated for oral use and contains sodium iodide i-131 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Jubilant Draximage Inc., Dba Jubilant Radiopharma on April 07, 2003. The current certification is valid through December 31, 2026.
How is this Jubilant Draximage Inc., Dba Jubilant Radiopharma product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65174088000. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.